SCIENTIFIC BACKGROUND

AIRE, ANOS1, BMP15, CAPN10, CHD7, CYP11A1, CYP17A1, CYP19A1, DENND1A, DUSP6, EIF2B2, EIF2B3, FEZF1, FGF8, FGF17, FGFR1, FIGLA, FLRT3, FMR1, FOXL2, FSHB, FSHR, GALT, GDF9, GNAS, GNRH1, GNRHR, HESX1, HS6ST1, IL17RD, INS, INSR, IRS1, IRS2, KISS1, KISS1R, LHB, LHCGR, NOBOX, NR5A1, NSMF, POF1B, POLG, PROK2, PROKR2, PSMC3IP, SEMA3A, SPRY4, STAG3, TAC3, TACR3, THADA, WDR11, WT1, ZP1

Category:

Scientific Background

Up to 10% of women have a genetic mutation (change in the DNA) which is linked with infertility.

Rodinia female panel screens for single nucleotide variants, insertions and deletions, as well as copy number variants in genes associated with female infertility. The panel also detects whole, partial and mosaic sex chromosome changes. Infertility genetic testing can guide treatment or clinical management options, enable early interventions to preserve fertility, and provide accurate prognostic assessment which can lead to a personalized clinical course of action.

 

Who is this test for?

• Individuals experiencing pregnancy delay

• Individuals with specific phenotype indicating a genetic syndrome associated with a sex chromosome aneuploidy

• Individuals with irregular or absent menstruation

• Individuals that will undergo assisted reproductive technology (ART) treatment

• Candidates for oocyte donation

• Individuals with family history of infertility 

 

Recommendations by professional bodies

Fragile X premutation carrier screening is recommended from the American College of Obstetricians and Gynecologists for women with a family history of fragile X-related disorders or intellectual disability suggestive of fragile X syndrome who are considering pregnancy or are currently pregnant. Women under 40 years old with unexplained ovarian insufficiency, or women with a family history of fragile X who are considering pregnancy or are currently pregnant are also recommended to have FMR1 premutation carrier screening. ACOG 2017

 

References

Committee Opinion No. 691 Summary: Carrier Screening for Genetic Conditions. (2017). Obstetrics and gynecology, 129(3), 597–599. https://doi.org/10.1097/AOG.0000000000001948

NORD. (n.d.). Fragile X Syndrome. National Organization for Rare Disorders. Retrieved October 2021, from https://rarediseases.org/rare-diseases/fragile-x-syndrome/

Dukhovny S, Wilkins-Haug L. Genetic Basis of Female Infertility. In: Murray MF, Babyatsky MW, Giovanni MA, Alkuraya FS, Stewart DR. eds. Clinical Genomics: Practical Applications in Adult Patient Care, 1e. McGraw Hill; 2014. Accessed March 29, 2023. https://accessmedicine.mhmedical.com/content.aspx?bookid=1094&sectionid=61904709

Cariati F, D'Argenio V, Tomaiuolo R. The evolving role of genetic tests in reproductive medicine. J Transl Med. 2019;17(1):267. Published 2019 Aug 14. doi:10.1186/s12967-019-2019-8

 

How many genes are tested in this panel?

55 genes, plus X chromosome aneuploidies

 

What diseases are associated with the genes tested in this panel?

• Primary ovarian insufficiency

• Polycystic ovary syndrome

• Ovarian hyperstimulation syndrome

• Hypogonadotropic hypogonadism disorders, such as Kallmann syndrome

• Disorders of sexual development

GENES

AIRE, ANOS1, BMP15, CAPN10, CHD7, CYP11A1, CYP17A1, CYP19A1, DENND1A, DUSP6, EIF2B2, EIF2B3, FEZF1, FGF8, FGF17, FGFR1, FIGLA, FLRT3, FMR1, FOXL2, FSHB, FSHR, GALT, GDF9, GNAS, GNRH1, GNRHR, HESX1, HS6ST1, IL17RD, INS, INSR, IRS1, IRS2, KISS1, KISS1R, LHB, LHCGR, NOBOX, NR5A1, NSMF, POF1B, POLG, PROK2, PROKR2, PSMC3IP, SEMA3A, SPRY4, STAG3, TAC3, TACR3, THADA, WDR11, WT1, ZP1

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more